Eron 2010

Eron JJ, Young B, Cooper DA, et al., and the SWITCHMRK 1 and 2 investigators. Switch to a Raltegravir-based regimen versus continuation of a Lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viremia (SWITCHMRK 1 and 2): Two multicentre, double-blind, randomized controlled trials. Lancet. 2010;375:396-407.
Type
Journal Article
Title
Switch to a Raltegravir-based regimen versus continuation of a Lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viremia (SWITCHMRK 1 and 2): Two multicentre, double-blind, randomized controlled trials
Source
Lancet. 2010;375:396-407
1st Author
Eron JJ
Authors
Eron JJ
Young B
Cooper DA
Year
2010
Page(s)
396-407

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1705 DeSales Street NW, Suite 700
Washington, D.C. 20036

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.